Cancer is often treated with chemotherapy, which tries to kill any fast-growing cells — sometimes killing healthy cells in the process. Drugs called targeted therapies and immunotherapies can more carefully select the cells they kill, making it easier to stop only the cells with mutations, and leaving healthy cells to grow normally.

By using comprehensive genomic profiling to identify the mutations in your cancer, your doctor can determine if a targeted therapy or immunotherapy may work, and which one to select for you.

The implementation of PGX testing helps physicians make informed treatment decisions. This will lead to better outcomes by decreasing adverse drug events and by increasing the effectiveness of drugs.

This approach to treatment is called precision medicine or personalized medicine, because it is based on your own unique genomic profile and cancer type. Our PGx profile provides accurate and reliable details on how your body metabolizes medications and suggests alternative prescriptions when increased sensitivity or reduced response is likely.

We are committed to delivering high-quality, affordable testing, to everyone who can benefit from it.

Our billing and reimbursement services are designed to make genetic testing accessible to patients regardless of their financial situation. Depending on the specific test, you may already have coverage through Medicare or private insurance.

For many patients who meet the medical necessity for testing, CGX and PGX is covered by Medicare at no cost.

If you are a Medicare recipient and you meet the following criteria, you may not have out-of-pocket expenses for your genetic cancer testing:

• You have Original/Traditional Medicare [Part B] reflecting on your insurance card.
• You have either existing, recurrent, relapsed, refractory, metastatic, or advanced stages III or IV cancer. OR you have a family ancestry or history of specific or rare cancers that may put you at higher risk than the normal population for developing cancer;
• This is your first time having a CGX or PGX test for this cancer diagnosis OR you had a test before, but this is a different type of cancer—a “new primary” cancer diagnosis; and
• Your test is ordered by one of our physicians.

We provide our patients with a comprehensive report of genetic variants and risk factors, so they understand their risk of developing cancer. We are able to search for specific genetic variants that put one at an increased risk of Hereditary Cancer, by analyzing a person's DNA and by using the latest advances in Next Generation Sequencing (NGS).

Sample CGX Report

Sample PGx Report